Drug Type Autologous CAR-T |
Synonyms |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD22 modulators(CD22 modulators), CD8 modulators(Cluster of differentiation 8 modulators) + [2] |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | US | - | |
Chronic Lymphocytic Leukemia | Preclinical | US | - | |
Non-Hodgkin Lymphoma | Preclinical | US | - |